Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 4/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 3/20 | 0.42 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | CALCRL | Q16602 | 3/20 | 0.41 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.40 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.40 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | RAMP3 | O60896 | 2/20 | 0.39 |
| ▸ | CALCR | P30988 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30449622 | 0.90 | KEAP1 (0.48) | CAPN1KEAP1STAT3SLC6A2CALCRL | |
| SCHEMBL29498765 | 0.88 | CAPN1 (0.48) | CAPN1STAT3SLC6A2CALCRLNTSR2 | |
| SCHEMBL8626712 | 0.88 | SLC6A2 (0.49) | CAPN1STAT3SLC6A2CALCRLNTSR2 | |
| SCHEMBL8627850 | 0.88 | SLC6A2 (0.49) | CAPN1STAT3SLC6A2CALCRLNTSR2 | |
| SCHEMBL22342218 | 0.87 | KEAP1 (0.54) | KEAP1CALCRLRAMP3CALCR | |
| SCHEMBL30335608 | 0.87 | KEAP1 (0.49) | CAPN1KEAP1STAT3SLC6A2CALCRL | |
| SCHEMBL26186023 | 0.87 | KEAP1 (0.49) | CAPN1KEAP1STAT3SLC6A2CALCRL | |
| SCHEMBL26186082 | 0.87 | KEAP1 (0.49) | CAPN1KEAP1STAT3SLC6A2CALCRL | |
| SCHEMBL30585207 | 0.87 | CALCRL (0.46) | CAPN1STAT3SLC6A2CALCRLNTSR2 | |
| SCHEMBL8625474 | 0.85 | CAPN1 (0.53) | CAPN1SLC6A2CALCRLNTSR2NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4448561-A2 | COMPOSITIONS AND METHODS FOR TREATING DISEASE | Dana-Farber Cancer Institute, Inc. (US) | 2024-10-23 | — | — | EP | claimed |
| CN-117343197-A | Recombinant fusion antibodies | 中山大学 | 2024-01-05 | — | — | CN | claimed |
| WO-2023114847-A2 | COMPOSITIONS AND METHODS FOR TREATING DISEASE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-06-22 | — | — | WO | claimed |
| CN-115975039-A | Recombinant fusion antibodies and antibody-drug conjugates and uses thereof | 中山大学 | 2023-04-18 | — | — | CN | claimed |
| CN-114931651-B | Targeting-drug based on antibody IgG1-Fc structural domain, and preparation method and application thereof | 武汉大学 | 2025-03-04 | — | — | CN | disclosed |
| CN-116042766-B | Composition, method and application for measuring protein ligase activity based on bioluminescence | 同济大学 | 2025-02-11 | — | — | CN | disclosed |
| CN-114478420-B | Multi-specific biological coupling connecting arm and synthesis method thereof | 北京大学 | 2025-02-07 | — | — | CN | disclosed |
| CN-117597451-B | Enhanced HMO formation by modifying intracellular lactose import | 帝斯曼知识产权资产管理有限公司 | 2024-12-24 | — | — | CN | disclosed |
| CN-113811317-B | Mutant VSV ectodomain polypeptides and uses thereof | 国家科学研究中心 | 2024-12-20 | — | — | CN | disclosed |
| CN-113646325-B | Peptides and compounds binding to extension initiation factor 4E | 新加坡科技研究局 | 2024-11-15 | — | — | CN | disclosed |
| CN-118974251-A | Conjugate of nucleic acid or derivative thereof and cell, preparation method and application thereof | 西湖大学 | 2024-11-15 | — | — | CN | disclosed |
| CN-116286562-B | Genetically engineered bacterium and preparation method and application thereof | 虹摹生物科技(上海)有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-114573714-A | Conjugate for target molecule modification and preparation method thereof | 北京大学 | 2022-06-03 | — | — | CN | disclosed |
| CN-114573707-A | Novel anti-tumor IL-15 fusion protein | 北京志道生物科技有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-110913908-B | MSLN-targeting trispecific proteins and methods of use | 哈普恩治疗公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114478420-A | Multi-specific biological coupling connecting arm and synthetic method thereof | 北京大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-114341637-A | Immunosensor | 联邦科学工业研究组织 | 2022-04-12 | — | — | CN | disclosed |
| CN-114269908-A | Engineered trans-enoyl COA reductase and preparation method and using method thereof | 基因组股份公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-114173824-A | Antibody drug conjugates | 武田药品工业株式会社 | 2022-03-11 | — | — | CN | disclosed |
| CN-114106091-A | Protein analogs and conjugates thereof | 正大天晴药业集团股份有限公司 | 2022-03-01 | — | — | CN | disclosed |